Treatment Options for urinary tract infections caused by extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae
No Thumbnail Available
Meeting name
Sponsors
Date
Journal Title
Format
Article
Subject
Abstract
Increased utilization of antibiotics has contributed to greater resistance among pathogenic bacteria. The prevalence of such organisms has created challenges for practitioners treating bacterial infections. One of the most frequently encountered infections in both inpatient and outpatient settings is urinary tract infections (UTIs). is the most commonly isolated uropathogen. Both and are capable of producing extended-spectrum B-lactamases (ESBL) which result in resistance to many antibiotics that are typically used in the treatment of UTIs. An analysis of inpatient urinary isolates in the United States found rates of ESBL-producing (ESBL-EC) and (ESBL-KP) to be 6.8[percent] and 10.3[percent], respectively.
Table of Contents
DOI
PubMed ID
Degree
Thesis Department
Rights
OpenAccess.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.